Global Wellness Times
SEE OTHER BRANDS

Global take on healthcare and wellness news

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on May 29, 2025

Study Reveals Olive Oil Helps Prevent Weight Gain, Unlike Butter and Margarine

Study Reveals Olive Oil Helps Prevent Weight Gain, Unlike Butter and Margarine

A recent study shows olive oil prevents weight gain, while butter and margarine contribute to it, highlighting olive oil's health benefits over other fats. LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- A recent study published in The …

KENTEX Launches Limited Edition Evangelion Racing 15th Anniversary Watch – Limited to 99 Pieces Worldwide

KENTEX Launches Limited Edition Evangelion Racing 15th Anniversary Watch – Limited to 99 Pieces Worldwide

KENTEX ignites Evangelion Racing’s 15th anniversary with a bold, Unit-01-inspired chronograph watch. Only 99 exist for the most devoted fans. TOKYO, JAPAN, May 29, 2025 /⁨EINPresswire.com⁩/ -- A landmark collaboration between Japan's premier watchmaker …

Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO

Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO

IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital™ pathology solutions, is excited to announce its participation in the upcoming American Society of Clinical Oncology ( …

Meet&Co Debuts Linora Collection, Emphasizing Green Office Environments

Meet&Co Debuts Linora Collection, Emphasizing Green Office Environments

SYDNEY , AUSTRALIA, May 29, 2025 /⁨EINPresswire.com⁩/ -- Leading China wholesale office furniture brand Meet…

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed that the Company is aware of the news …

Kane Biotech Announces First Quarter 2025 Financial Results

Kane Biotech Announces First Quarter 2025 Financial Results

WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its first quarter 2025 financial results. First Quarter 2025 Financial Highlights (Comparatives Exclude …

Bicycle Shoe Market Poised for Growth by 2035, Driven by Fitness Boom, E-Bike Popularity, and Urban Mobility Trends

Bicycle Shoe Market Poised for Growth by 2035, Driven by Fitness Boom, E-Bike Popularity, and Urban Mobility Trends

Global Bicycle Shoe Market Set for Strong Growth by 2035, Driven by Fitness Trends, E-Bike Adoption, and Sustainable Urban Commuting NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global bicycle shoe market is poised for steady growth …

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow …

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conference on Tuesday, …

Verizon Dominates Indy 500 Data Connectivity

Verizon Dominates Indy 500 Data Connectivity

INDIANAPOLIS, May 29, 2025 (GLOBE NEWSWIRE) -- The 2025 Indianapolis 500 race set a new milestone for data usage and connection at the Indianapolis Motor Speedway on the Verizon network. In just one day, inside the Indianapolis Motor Speedway, a total of …

Zevra Announces Final Results of 2025 Annual Meeting of Stockholders

Zevra Announces Final Results of 2025 Annual Meeting of Stockholders

Zevra Stockholders Re-Elect Wendy L. Dixon, Ph.D. and Tamara A. Favorito to the Company’s Board of Directors Board and Management Reaffirm Commitment to Driving Continued Growth and Progress Against Strategic Plan CELEBRATION, Fla., May 29, 2025 (GLOBE …

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

FRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients …

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025 …

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office …

Alumis to Present at the Jefferies Global Healthcare Investor Conference

Alumis to Present at the Jefferies Global Healthcare Investor Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President …

CooperCompanies Announces Second Quarter 2025 Results

CooperCompanies Announces Second Quarter 2025 Results

SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. Revenue increased 6% year-over-year to $1,002. …

THOR Industries Announces Participation in Upcoming Investor Conference

THOR Industries Announces Participation in Upcoming Investor Conference

ELKHART, Ind., May 29, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the management team will be participating in an upcoming investor conference. THOR management will be hosting a fireside chat along with one-on-one …

Fulcrum Therapeutics to Present at Upcoming Medical Meetings

Fulcrum Therapeutics to Present at Upcoming Medical Meetings

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service